Article Details
Retrieved on: 2021-06-01 14:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The first commercial product of Puyi Biotechnology, "Xiangtong® Fully Bioabsorbable Drug-Coated Sinus Implant," was approved in April 2017 by the ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here